Tag

PharmaCielo says it has more than doubled revenue to $3.8 million in the first nine months of 2022.

Flora Growth grows, cultivates, and develops products derived from medicinal cannabis that are sold to pharmacies, clinics, and cosmetic businesses worldwide.

PharmaCielo’s CEO claimed its business has made progress in several markets, including Germany, Israel, Brazil, Mexico, Poland, and now, the Czech Republic.

Merchan says the change by the Ministry of Health puts Colombia at the vanguard for medicinal cannabis in the world.

Extractions Solutions intends to use PharmaCielo's product to develop CBD derivatives to be produced in Spain and distributed across Europe.

The new law enables domestic production and marketing of non-psychoactive cannabis products, and further defines import and export rules.

The export of the high-THC product is pending the dried-flower checklist from the Colombian government from the 2021 update to the cannabis law.

Medical marijuana derivatives are included in the expansive resolution for the first time, though some private insurers had already included cannabis trreatments.

Flora Growth Corp (NASDAQ: FLGC) last month became the first ever cannabis cultivator to list on the NASDAQ stock exchange in the US without using a SPAC (Special Purpose Acquisition Company), reverse merger, or dual listing, and became the first all-outdoor cannabis grower to...

Like several other companies in Colombia, Khiron (TSX.V: KHRNF) cultivates and processes cannabis at its agricultural facilities in Ibagué, Tolima. But Khiron takes the unique approach of launching and operating a chain of integrative medical clinics under its Zerenia brand,...